Pure Global

Qualitative Assay Kit for Influenza A, Influenza B, RSV A, RSV B and Influenza A - H1, - H3, and - H1pdm09 - Vietnam Registration 2400197ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative Assay Kit for Influenza A, Influenza B, RSV A, RSV B and Influenza A - H1, - H3, and - H1pdm09 in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2400197ĐKLH/BYT-HTTB and manufactured by Seegene, Inc.. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ Y TẾ PHƯƠNG ĐÔNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2400197ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2400197ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative Assay Kit for Influenza A, Influenza B, RSV A, RSV B and Influenza A - H1, - H3, and - H1pdm09
VN: Bộ xét nghiệm định tính ARN virus cúm A, cúm B, RSV A, RSV B và chủng cúm A - H1,- H3, và - H1pdm09
Risk Class TTBYT Loại C

Registration Details

2400197ĐKLH/BYT-HTTB

000.00.04.G18-211214-0022

Allplex™ Respiratory Panel 1

RP9801Y

Company Information

REPUBLIC OF

Technical Details

Qualitative in vitro testing to detect single or multiple strains of Influenza A virus (Flu A), Influenza B virus (Flu B), Human respiratory syncytial virus A (RSV A), Human respiratory syncytial virus B (RSV B), Human Influenza A virus subtype H1 (Flu A-H1), Human Influenza A virus subtype H3 (Flu A-H3), and Human Influenza A virus subtype H1pdm09 (Flu A-H1pdm09) from the nasopharyngeal aspirate, nasopharyngeal swab, and bronchoalveolar lavage samples.

Dates and Status

Feb 04, 2024